Ronald Labonté

Sep 9, 2024 | msn.com | Joel Lexchin |Brigitte Tenni |Deborah Gleeson |Ronald Labonté

Continue reading More for You   Continue reading More for You

Sep 9, 2024 | medicalxpress.com | Joel Lexchin |Brigitte Tenni |Deborah Gleeson |Ronald Labonté

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:Africa says it needs an estimated 10 million doses of mpox vaccine to control this public health emergency. The situation is particularly concerning in the Democratic Republic of the Congo, which has reported more than 27,000 suspected mpox cases and more than 1,300 deaths so far this year.

Sep 8, 2024 | theconversation.com | Joel Lexchin |Brigitte Tenni |Deborah Gleeson |Ronald Labonté

Joel Lexchin has received payments for writing a brief on the role of promotion in generating prescriptions for a legal firm, for being on a panel about pharmacare and for co-writing an article for a peer-reviewed medical journal. He is a member of the Boards of Canadian Doctors for Medicare and the Canadian Health Coalition. He receives royalties from University of Toronto Press and James Lorimer & Co. Ltd. for books he has written.

Oct 27, 2022 | peoplesdispatch.org | Ronald Labonté

Oct 18, 2022 | globalizationandhealth.biomedcentral.com | Ronald Labonté |Greg Martin